Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of First China Pharmaceutical Group, Inc. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zhen Jiang Wang, Chief Executive Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

	i.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

	ii.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of

Date: August 20, 2012

/s/ Zhen Jiang Wang
Name: Zhen Jiang Wang
Title: Chief Executive Officer (Principal Executive Officer)

FIRST CHINA PHARMACEUTICAL GROUP, INC. 10-Q